AAAAAA

   
Results: 1-9 |
Results: 9
Chemoimmunotherapy of cancer: Potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A
Authors: Indrova, M Bubenik, J Simova, J Bieblova, J Jandlova, T Smahel, M Vonka, V Glazman-Kusnierczyk, H Pajtasz-Piasecka, E Radzikowski, C Mikyskova, R
Citation: M. Indrova et al., Chemoimmunotherapy of cancer: Potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A, ONCOL REP, 8(6), 2001, pp. 1371-1374
Local cytokine treatment of HPV16-associated tumours results in inhibitionof their lung metastases
Authors: Mikyskova, R Bubenik, J Mendoza, L Vonka, V Smahel, M Simova, J Jandlova, T
Citation: R. Mikyskova et al., Local cytokine treatment of HPV16-associated tumours results in inhibitionof their lung metastases, CLIN EXP M, 18(7), 2001, pp. 581-587
Modified HPV16 E7 genes as DNA vaccine against E7-containing oncogenic cells
Authors: Smahel, M Sima, P Ludvikova, V Vonka, V
Citation: M. Smahel et al., Modified HPV16 E7 genes as DNA vaccine against E7-containing oncogenic cells, VIROLOGY, 281(2), 2001, pp. 231-238
Metastatic MHC class I-negative mouse cells derived by transformation withhuman papillomavirus type 16
Authors: Smahel, M Sobotkova, E Bubenik, J Simova, J Zak, R Ludvikova, V Hajkova, R Kovarik, J Jelinek, F Povysil, C Marinov, J Vonka, V
Citation: M. Smahel et al., Metastatic MHC class I-negative mouse cells derived by transformation withhuman papillomavirus type 16, BR J CANC, 84(3), 2001, pp. 374-380
Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth
Authors: Mendoza, L Indrova, M Hajkova, R Reinis, M Smahel, M Vonka, V Bubenik, J Jandlova, T
Citation: L. Mendoza et al., Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth, FOL BIOL, 46(3), 2000, pp. 91-97
DNA vaccine against oncogenic hamster cells transformed by HPV16 E6/E7 oncogenes and the activated ras oncogene
Authors: Smahel, M Sobotkova, E Vonka, V Hamsikova, E Zak, R Kitasato, H Ludvikova, V
Citation: M. Smahel et al., DNA vaccine against oncogenic hamster cells transformed by HPV16 E6/E7 oncogenes and the activated ras oncogene, ONCOL REP, 6(1), 1999, pp. 211-215
Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16
Authors: Bubenik, J Simova, J Hajkova, R Sobota, V Jandlova, T Smahel, M Sobotkova, E Vonka, V
Citation: J. Bubenik et al., Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16, INT J ONCOL, 14(3), 1999, pp. 593-597
Human papillomavirus genotype spectrum in Czech women: Correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles
Authors: Tachezy, R Hamsikova, E Hajek, T Mikyskova, I Smahel, M Van Ranst, M Kanka, J Havrankova, A Rob, L Guttner, V Slavik, V Anton, M Kratochvil, B Kotrsova, L Vonka, V
Citation: R. Tachezy et al., Human papillomavirus genotype spectrum in Czech women: Correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles, J MED VIROL, 58(4), 1999, pp. 378-386
Prospective study on cervical neoplasia IV. Presence of HPV antibodies
Authors: Vonka, V Hamsikova, E Kanka, J Ludvikova, V Sapp, M Smahel, M
Citation: V. Vonka et al., Prospective study on cervical neoplasia IV. Presence of HPV antibodies, INT J CANC, 80(3), 1999, pp. 365-368
Risultati: 1-9 |